Thus, genetic or pharmacological inhibition of Drp1 improved muscle insulin sensitivity and insulin signaling in obese mice, as well as conferred protection against high-fat diet-induced obesity in liver-specific Drp1 deleted mice [95,96]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.